Friday, September 03, 2021 1:49:40 PM
New York Yankees and Duke Basketball
Recent IPHA News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2024 11:00:58 AM
- Innate Pharma présente ses résultats financiers au troisième trimestre 2024 • Business Wire • 11/13/2024 06:00:00 AM
- Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results • Business Wire • 11/13/2024 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/08/2024 11:00:41 AM
- Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024 • Business Wire • 11/08/2024 06:00:00 AM
- Innate Pharma annonce les présentations de données de son portefeuille innovant en oncologie sélectionnées pour le congrès annuel du SITC 2024 • Business Wire • 11/08/2024 06:00:00 AM
- Innate Pharma organise une conférence téléphonique pour ses résultats financiers et l’avancée de son portefeuille au troisième trimestre 2024 • Business Wire • 11/07/2024 06:00:00 AM
- Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates • Business Wire • 11/07/2024 06:00:00 AM
- Innate Pharma Announces Its Participation in Upcoming Investor Conferences • Business Wire • 10/29/2024 06:00:00 AM
- Innate Pharma annonce sa participation à de prochaines conférences investisseurs • Business Wire • 10/29/2024 06:00:00 AM
- Jonathan Dickinson est nommé Président du Directoire d’Innate Pharma • Business Wire • 10/14/2024 05:00:00 AM
- Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board • Business Wire • 10/14/2024 05:00:00 AM
- Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024 • Business Wire • 09/30/2024 05:00:00 AM
- Innate Pharma co-organise un symposium scientifique en présence d’experts de l’Immunotherapie à New York le 3 octobre 2024 • Business Wire • 09/30/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 10:03:48 AM
- Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors • Business Wire • 09/23/2024 05:00:00 AM
- Innate Pharma reçoit l’autorisation de l’agence américaine du médicament d’initier le développement clinique d’IPH4502, son ADC ciblant Nectine-4, dans les tumeurs solides • Business Wire • 09/23/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/12/2024 10:15:07 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/12/2024 10:07:46 AM
- U.S. Index Futures Climb Ahead of Key Economic Data Releases; Oil Prices Rise • IH Market News • 09/12/2024 10:04:12 AM
- Innate Pharma Reports First Half 2024 Business Update and Financial Results • Business Wire • 09/12/2024 05:00:00 AM
- Innate Pharma présente l’avancée de son portefeuille et ses résultats financiers au premier semestre 2024 • Business Wire • 09/12/2024 05:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/11/2024 08:00:52 PM
- Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024 • Business Wire • 09/09/2024 05:00:00 AM
- Innate Pharma SA: Présentation de données de monalizumab issues de l’étude de Phase 2 NeoCOAST-2 dans le cancer du poumon non à petites cellules au stade précoce à la conférence mondiale sur le cancer du poumon 2024 • Business Wire • 09/09/2024 05:00:00 AM
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM